Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kazuki Takada

Showing results (1-10 of 164) with videos related to

Pageof 17
Sort By:
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|May 23, 2017
Active learning-how to engage students in effective learningKazuki Takada
JTO Clinical and Research Reports|August 9, 2023
Correspondence Regarding "Sleeve Lobectomy After Neoadjuvant Chemoimmunotherapy Versus Chemotherapy for Squamous Cell Lung Cancer: A Multicenter, Retrospective Study"Kazuki Takada, Shinkichi Takamori
Lung Cancer (Amsterdam, Netherlands)|July 10, 2022
Comments on "Lymphocyte-to-monocyte ratio is an independent prognostic factor in surgically treated small cell lung cancer: An international multicenter analysis"Kazuki Takada, Shinkichi Takamori
Autoimmunity|October 18, 2005
Polymyositis/dermatomyositis and interstitial lung disease: a new therapeutic approach with T-cell-specific immunosuppressantsKazuki Takada, Kenji Nagasaka, Nobuyuki Miyasaka
Modern Rheumatology|April 18, 2007
Step-up versus primary intensive approach to the treatment of interstitial pneumonia associated with dermatomyositis/polymyositis: a retrospective studyKazuki Takada, Jun Kishi, Nobuyuki Miyasaka
Annals of Surgical Oncology|August 2, 2019
ASO Author Reflections: Clinical Implications of Programmed Death-Ligand 2 (PD-L2) Expression as an Independent Prognostic Marker in Lung Adenocarcinoma: Different Characteristics of PD-L2-Positive Patients from Those with Programmed Death-Ligand 1Shinkichi Takamori, Kazuki Takada, Yoshihiko Maehara
Annals of Surgical Oncology|August 7, 2019
ASO Author Reflections: PD-L2 Expression in Lung Squamous Cell Carcinoma-One of the Potential Important Prognostic FactorsTaichi Matsubara, Kazuki Takada, Yoshihiko Maehara
Annals of Surgical Oncology|July 18, 2024
ASO Author Reflections: Relationship Between SIRPα Expression on Tumor-Associated Macrophages and Tumor Microenvironment in Lung Squamous Cell CarcinomaTaichi Nagano, Kazuki Takada, Tomoyoshi Takenaka, et al.
Bioorganic & Medicinal Chemistry|March 6, 2010
Structural basis for the design of novel Schiff base metal chelate inhibitors of trypsinDaisuke Iyaguchi, Susumu Kawano, Kazuki Takada, et al.
The Journal of Rheumatology|October 3, 2012
Renal involvement in antimyeloperoxidase antineutrophil cytoplasmic antibody-positive granulomatosis with polyangiitis with chronic hypertrophic pachymeningitisHisanori Hasegawa, Hitoshi Kohsaka, Kazuki Takada, et al.
Pageof 17

Showing results (1-10 of 164) with videos related to

Sort By:
Pageof 17
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|May 23, 2017
Active learning-how to engage students in effective learningKazuki Takada
JTO Clinical and Research Reports|August 9, 2023
Correspondence Regarding "Sleeve Lobectomy After Neoadjuvant Chemoimmunotherapy Versus Chemotherapy for Squamous Cell Lung Cancer: A Multicenter, Retrospective Study"Kazuki Takada, Shinkichi Takamori
Lung Cancer (Amsterdam, Netherlands)|July 10, 2022
Comments on "Lymphocyte-to-monocyte ratio is an independent prognostic factor in surgically treated small cell lung cancer: An international multicenter analysis"Kazuki Takada, Shinkichi Takamori
Autoimmunity|October 18, 2005
Polymyositis/dermatomyositis and interstitial lung disease: a new therapeutic approach with T-cell-specific immunosuppressantsKazuki Takada, Kenji Nagasaka, Nobuyuki Miyasaka
Modern Rheumatology|April 18, 2007
Step-up versus primary intensive approach to the treatment of interstitial pneumonia associated with dermatomyositis/polymyositis: a retrospective studyKazuki Takada, Jun Kishi, Nobuyuki Miyasaka
Annals of Surgical Oncology|August 2, 2019
ASO Author Reflections: Clinical Implications of Programmed Death-Ligand 2 (PD-L2) Expression as an Independent Prognostic Marker in Lung Adenocarcinoma: Different Characteristics of PD-L2-Positive Patients from Those with Programmed Death-Ligand 1Shinkichi Takamori, Kazuki Takada, Yoshihiko Maehara
Annals of Surgical Oncology|August 7, 2019
ASO Author Reflections: PD-L2 Expression in Lung Squamous Cell Carcinoma-One of the Potential Important Prognostic FactorsTaichi Matsubara, Kazuki Takada, Yoshihiko Maehara
Annals of Surgical Oncology|July 18, 2024
ASO Author Reflections: Relationship Between SIRPα Expression on Tumor-Associated Macrophages and Tumor Microenvironment in Lung Squamous Cell CarcinomaTaichi Nagano, Kazuki Takada, Tomoyoshi Takenaka, et al.
Bioorganic & Medicinal Chemistry|March 6, 2010
Structural basis for the design of novel Schiff base metal chelate inhibitors of trypsinDaisuke Iyaguchi, Susumu Kawano, Kazuki Takada, et al.
The Journal of Rheumatology|October 3, 2012
Renal involvement in antimyeloperoxidase antineutrophil cytoplasmic antibody-positive granulomatosis with polyangiitis with chronic hypertrophic pachymeningitisHisanori Hasegawa, Hitoshi Kohsaka, Kazuki Takada, et al.
Pageof 17